Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why Dynavax Stock Is Rising Today

TheMotleyFool

0 0

Shares of Dynavax Technologies (NASDAQ: DVAX) were up by 3.6% as of 11:38 a.m. EDT on Thursday after having gained as much as 6.9% earlier in the session. The stock's rise came following the company's announcement that it has signed a deal with Bavarian Nordic to market and distribute its hepatitis B vaccine Heplisav B in Germany.

Dynavax received market authorization for Heplisav B from the European Commission in February. However, that regulatory win was only the first step for the company in commercializing its hepatitis B vaccine throughout the European Union.

Image source: Getty Images.

Source Fool.com

Like: 0

DVAX

Teilen